Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Betmiga (mirabegron) - Important Safety Information from Astellas Pharma Co., Ltd. as approved by the HPRA
Notice type:
3rd Party Publications
Date:
09/09/2015
Problem Or Issue:
Important Safety Information communication from Astellas Pharma Co., Ltd. on new recommendations about risk of increase in blood pressure associated with Betmiga (mirabegron).
Important Safety Information - Betmiga (mirabegron)
« Back
Date Printed: 27/04/2024